STAY INFORMED  
line decor
   If you suspect anyone of showing symptoms of the 'Necro- Mortosis' Virus, the Government has released the following anonymous tip line. 1 800 155 3219
line decor
 
 


Bookmark and Share
 

 
 
What is science doing to combat it?

Vaccine facts:

A Mortosis virus vaccine is not currently available for use in the United States.

Test drugs: The Mortosis Inhibitor XL-6 is currently undergoing phase four tests.

According to Amcalon Corporation's web site, in reference to XL-6 Test results: 'Studies in Berlin suggest that Antiviral test drugs can interrupt the process by which a virus reproduces at several stages. The inhibitor XL-6, for example, prevents the virus particle from opening after it enters the cell and can inhibit the manufacture of virus proteins. It also stop the virus from exiting the cell.'



virus vaccine is not currently available for use in the United States.

Test drugs: The Mortosis Inhibitor XL-6 is currently undergoing phase four tests.

According to Amcalon Corporation's web site, in reference to XL-6 Test results: 'Studies in Berlin suggest that Antiviral test drugs can interrupt the process by which a virus reproduces at several stages. The inhibitor XL-6, for example, prevents the virus particle from opening after it enters the cell and can inhibit the manufacture of virus proteins. It also stop the virus from exiting the cell.'

.

Early quarantine is essential. To reduce the chance of spreading the infection beyond the carrier , a professional quarantine must be given within 24 hours of first symptoms.

None effective procedures: Streptomycin, gentamicin, the tetracyclines, and chloramphenicol are all NONE effective against Necrotic plague.

Effective procedures: Avoid contact with open wounds , sores or saliva of first and second stage carriers. Avoiding all physical contact with second stage sufferers is essential. Wearing a close-fitting surgical mask also helps protect against infection.

 

 

 

 
 

 

Systematic Treatment and Case Management

Standard public health approaches have proved to be insuficient, and inconsistent to Necro-Mortosis prevention and control efforts. However,newer initiatives include public health monitoring to ensure that all Necro-Mortosis infected patients receive quality quarantine care, providing public health support through referrals and outreach for patients who are not receiving effective councelingt, monitoring of cell counts and viral loads to identify patients who may be candidates for treatment or who are lost to care, and assisting clinicians with outreach and partner notification.

Although Necro-Mortosis infection remains incurable, the use of effective treatment that incorporates risk-reduction counseling, including distribution of literature, surgical gloves, face masks, and promotion of the use of condoms and clean needles, would improve individual exposure outcomes and reduce virus transmission,


 
 
    This site is for entertainment purposes only. All stories and events are fictional